证券代码：600389 证券简称：江山股份 公告编号：临 2023—044 南通江山农药化工股份有限公司 第九届董事会第五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 南通江山农药化工股份有限公司（以下简称"公司"）于 2023 年 8 月 4 日以 电子邮件方式向公司全体董事发出召开第九届董事会第五次会议的通知，并于 2023 年 8 月 16 日在南通五洲皇冠酒店以现场结合通讯表决的方式召开。本次会 议由董事长薛健先生主持，会议应参与表决董事 9 人，实际参与表决董事 9 人 （其中董事陈云光先生、独立董事张利军先生、方国兵先生以通讯方式参与表决）， 公司监事及部分高级管理人员列席了会议。会议的召集召开符合《公司法》和《公 司章程》的有关规定。与会董事对各项议案进行了逐项审议，并经书面表决形成 如下决议： 一、审议通过《公司 2023 年半年度报告》全文及摘要 表决结果：9 票同意、0 票反对、0 票弃权 具体内容详见公司同日在上海证券交易所网站披露的《江山股份 2023 年半 年度报告》全文及摘要。 二 ...

重要内容提示： 南通江山农药化工股份有限公司（以下简称"公司"）已于 2023 年 8 月 18 日发布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年上半年经营成果、财务状况，公司计划于 2023 年 8 月 25 日下午 15:00-16:00 举行 2023 年半年度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 证券代码：600389 证券简称：江山股份 公告编号：临 2023-047 南通江山农药化工股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 本次投资者说明会以网络互动形式召开，公司将针对 2023 年上半年的经营 成果及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范 围内就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 （一） 会议召开时间：2023 年 8 月 25 日 下午 15:00-16:00 1 会议召开时间：2023 年 8 月 25 日(星期五) 下午 15:00 ...

证券代码：600389 证券简称：江山股份 公告编号：临 2023—045 南通江山农药化工股份有限公司 第九届监事会第四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 南通江山农药化工股份有限公司（以下简称"公司"）于 2023 年 8 月 4 日以 电子邮件方式向公司全体监事发出召开第九届监事会第四次会议的通知，并于 2023 年 8 月 16 日以现场结合通讯方式召开。本次会议应参与表决监事 3 人，实 际参与表决监事 3 人，符合《公司法》和《公司章程》的有关规定。与会监事经 认真审议，并经书面表决形成了如下决议： 一、审议通过《公司 2023 年半年度报告》全文及摘要 表决结果：3 票同意、0 票反对、0 票弃权 公司监事会根据《证券法》第 82 条规定，对公司 2023 年半年度报告进行了 认真严格的审核，提出如下书面审核意见： 1、半年度报告的编制和审议程序符合法律、法规、公司章程和公司内部管 理制度的各项规定； 2、半年度报告的内容和格式符合中国证监会和上海证券交易所的各项规定， 所包含的信息从 ...

证券代码：600389 证券简称：江山股份 公告编号：临 2023—049 南通江山农药化工股份有限公司 关于向全资子公司增加注册资本的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 （一）对外投资的基本情况 为满足公司 JS-T205 等新产品产业化需要，完善产业布局，经公司第八届董 事会第二十次会议审议通过，公司对外投资设立了全资子公司江山（宜昌）作物 科技有限公司（以下简称"江山宜昌"）。根据公司战略发展规划及项目建设实际 需要，公司拟向江山宜昌增加注册资本 16,000 万元，本次增资完成后，江山宜 昌的注册资本由9,000万元增加至25,000万元，江山宜昌仍为公司全资子公司。 （二）审议情况 公司于 2023 年 8 月 16 日召开了第九届董事会第五次会议，审议通过了《关 于向全资子公司增加注册资本的议案》，根据《公司章程》的有关规定，该议案 无需提交公司股东大会审议。 本次对外投资事项不构成关联交易，也不涉及重大资产重组。 1 重要内容提示： 一、对外投资概述 投资标的名称：江山（宜昌）作物科技有限 ...

证券代码：600389 证券简称：江山股份 公告编号：临 2023—048 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 南通江山农药化工股份有限公司（以下简称"公司"）于 2023 年 8 月 16 日 召开了第九届董事会第五次会议，审议通过了《关于变更注册资本暨修订<公司 章程>的议案》，公司拟对注册资本进行变更，并修订《公司章程》相关条款，具 体如下： 一、注册资本变更情况 1、公司第九届董事会第三次会议及第九届监事会第三次会议审议通过了《关 于向2022年限制性股票激励计划激励对象授予预留限制性股票的议案》，确定以 2023年4月18日为预留授予日，以人民币19.04元/股的授予价格向13名授予激励 对象授予48.35万股限制性股票。上述股份已于2023年5月16日在中国证券登记结 算有限责任公司上海分公司完成登记工作，公司总股本由30,536.71万股变更为 30,585.06万股。 2、经公司2022年度股东大会审议通过,公司于2023年6月实施了2022年度利 润分配方案：以公司总股本305,850,600股为 ...

证券代码：600389 证券简称：江山股份 公告编号：临 2023-050 南通江山农药化工股份有限公司 项目投资公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、项目投资概述 为进一步优化产业结构，推进转型升级，实现高质量发展，南通江山农药化 工股份有限公司（以下简称"公司"）拟以全资子公司江山（宜昌）作物科技有 限公司（以下简称"江山宜昌"）为实施主体，在湖北枝江姚家港化工园区投资 79,498.82 万元建设"新型创制绿色除草剂原药及制剂项目"。 公司第九届董事会第五次会议审议通过了《关于实施"新型创制绿色除草剂 原药及制剂项目"的议案》，根据《公司章程》的相关规定，该议案无需提交股 东大会审议。 1 投资项目名称：新型创制绿色除草剂原药及制剂项目 投资金额：拟投资金额为 79,498.82 万元 相关风险提示：1、项目审批风险：本项目已取得立项、能评、环评、 安评等相关政府部门的批复文件，但后续项目建设、生产经营尚需根据 国家农药管理的相关规定取得相应的行政许可，存在审批不能获得通 过的风险。2 ...

证券代码：600389 证券简称：江山股份 公告编号：临 2023-046 南通江山农药化工股份有限公司 2023 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露：第十三 号—化工》、《关于做好主板上市公司 2023 年半年度报告披露工作的重要提醒》 的要求，南通江山农药化工股份有限公司（以下简称"公司"）现将 2023 年半年 度主要经营数据披露如下： 注 1：上述产量含自用量、农药按含量折原药计算（下同）。 注 2：除草剂产品包括草甘膦、酰胺类等产品；杀虫剂产品包括敌百虫、敌敌畏、二嗪 磷等产品；氯碱产品包括烧碱、盐酸、液氯、次氯酸钠等产品，其中烧碱产销量 按 32%、48%烧碱实物量计算（下同）。 注 3：阻燃剂（磷系）产品包含 TCPP、BDP 产品（下同）。 | 主要产品 | 2023 年 1-6 | | 月平 | | 2022 年 | 1-6 | 月平 | 同期变动比 | 第二季度环 比变动比率 | | | --- | --- ...

证券代码：600389 证券简称：江山股份 公告编号：临 2023—034 南通江山农药化工股份有限公司 关于接待投资者调研情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 南通江山农药化工股份有限公司（以下简称"公司"）于 2023 年 5 月 9 日通 过现场参观调研及电话会议交流等形式接待了部分投资者调研，现将调研具体情 况公告如下： 一、调研基本情况 调研时间：2023 年 5 月 9 日上午 9:00-12:00 调研方式：现场参观调研及电话会议交流 调研机构名称（排名不分先后）：鹏华基金、华泰保险、嘉实基金、国投瑞 银、平安基金、亘曦资产、申万宏源、中信证券、东北证券、自然人股东 公司接待人员：董事长薛健先生，副董事长刘为东先生，董事、总经理王利 先生，董事、常务副总经理孟长春先生，副总经理、董事会秘书兼财务负责人宋 金华先生。 二、主要交流内容 （一）公司未来发展战略介绍 2018 年公司通过对内外部环境的分析，结合公司发展的优劣势，将公司的 发展战略调整为：以"专业化、差异化、品牌化"为战略导向，"产 ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 1,352,672,296.69, representing a decrease of 50.25% compared to the same period last year[5]. - The net profit attributable to shareholders for Q1 2023 was CNY 123,637,564.73, down 80.86% year-on-year[5]. - The basic earnings per share for Q1 2023 was CNY 0.4163, reflecting an 80.86% decline compared to the previous year[6]. - Total operating revenue for Q1 2023 was ¥1,352,672,296.69, a decrease of 50.2% compared to ¥2,719,079,434.12 in Q1 2022[17]. - Net profit for Q1 2023 was ¥123,622,745.10, a decline of 81.0% compared to ¥651,775,603.73 in Q1 2022[18]. - Total comprehensive income for Q1 2023 was CNY 123,727,009.64, compared to CNY 651,792,919.22 in Q1 2022, indicating a significant decline[19]. - Basic and diluted earnings per share for Q1 2023 were CNY 0.4163, down from CNY 2.1745 in Q1 2022, reflecting a decrease of approximately 81.1%[19]. Cash Flow - The net cash flow from operating activities was CNY 96,813,722.53, a decrease of 72.23% year-on-year[5]. - Net cash flow from operating activities for Q1 2023 was CNY 96,813,722.53, a decrease of 72.8% from CNY 348,590,406.32 in Q1 2022[21]. - Cash inflow from operating activities totaled CNY 1,604,330,193.99 in Q1 2023, down 26.4% from CNY 2,180,216,077.52 in Q1 2022[20]. - Cash outflow from operating activities was CNY 1,507,516,471.46 in Q1 2023, compared to CNY 1,831,625,671.20 in Q1 2022, a decrease of 17.7%[21]. - Net cash flow from investing activities was -CNY 72,697,403.51 in Q1 2023, an improvement from -CNY 401,754,111.30 in Q1 2022[21]. - Net cash flow from financing activities was -CNY 5,753,101.18 in Q1 2023, compared to CNY 20,461,158.32 in Q1 2022, indicating a decrease in cash outflow[21]. - The ending balance of cash and cash equivalents as of March 31, 2023, was CNY 1,945,279,239.01, up from CNY 1,069,685,675.28 at the end of Q1 2022[21]. Assets and Liabilities - Total assets at the end of Q1 2023 were CNY 6,142,198,492.04, down 5.69% from the end of the previous year[6]. - The company's total assets decreased to ¥6,142,198,492.04 in Q1 2023 from ¥6,513,098,085.61 in Q1 2022, reflecting a reduction of 5.7%[16]. - Total liabilities decreased to ¥2,676,337,349.00 in Q1 2023 from ¥3,200,728,965.79 in Q1 2022, a decline of 16.3%[15]. - Total non-current liabilities amounted to approximately 830.27 million, with long-term borrowings at 602.46 million[26]. - Total liabilities reached approximately 3.20 billion, reflecting a slight decrease of 1.06 million compared to the previous period[26]. - The total liabilities and equity combined were approximately 6.51 billion, consistent with the company's financial strategy[26]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 22,180[10]. - The top shareholder, Nantong Industrial Holding Group Co., Ltd., holds 28.17% of the shares[10]. - The equity attributable to shareholders increased by 4.64% to CNY 3,463,093,571.42 compared to the end of the previous year[6]. - The company's equity attributable to shareholders increased to ¥3,463,093,571.42 in Q1 2023 from ¥3,309,586,728.58 in Q1 2022, an increase of 4.6%[16]. - The total equity attributable to shareholders was approximately 3.31 billion, with retained earnings at approximately 2.34 billion[26]. - The company reported a slight increase in undistributed profits by approximately 69.29 thousand, reaching 2.34 billion[26]. Research and Development - Research and development expenses for Q1 2023 were ¥42,249,446.03, down 45.5% from ¥77,378,908.59 in Q1 2022[17]. - The company did not report any new product developments or market expansion strategies during this quarter[12]. Accounting and Standards - The company adopted new accounting standards starting in 2023, which may impact financial reporting and asset recognition[22].

Dividend Distribution - The company plans to distribute a cash dividend of 2.00 CNY per 10 shares, totaling 61,073,420.00 CNY, which represents 3.31% of the net profit attributable to ordinary shareholders for the year[6]. - In 2022, the total cash dividends distributed amounted to 977,174,720.00 CNY, accounting for 52.98% of the net profit attributable to ordinary shareholders[6]. - The company intends to issue 0.45 bonus shares for every share held, increasing the total share capital to 442,782,295 shares[7]. - The company's total share capital as of December 31, 2022, was 305,367,100 shares, which serves as the basis for the dividend distribution calculations[171]. - The cash dividend distribution for the first half of 2022 was completed by September 30, 2022[170]. - The company's profit distribution plan has been approved by independent directors, ensuring compliance with company regulations and decision-making procedures[171]. Financial Performance - The company's operating revenue for 2022 reached ¥8,348,772,840.84, representing a year-on-year increase of 28.76% compared to ¥6,483,760,507.83 in 2021[23]. - The net profit attributable to shareholders of the listed company was ¥1,844,424,518.46 in 2022, a significant increase of 125.91% from ¥816,452,808.96 in 2021[23]. - The basic earnings per share for 2022 was ¥6.1257, up 122.83% from ¥2.7490 in 2021[24]. - The company's total assets increased by 14.68% to ¥6,513,098,085.61 at the end of 2022, compared to ¥5,679,443,510.79 at the end of 2021[23]. - The company achieved a net cash flow from operating activities of ¥1,773,699,279.71 in 2022, an increase of 78.48% from ¥993,795,032.81 in 2021[23]. - The weighted average return on net assets for 2022 was 60.85%, an increase of 24.17 percentage points from 36.68% in 2021[24]. Risk Management - The company has outlined various risks including safety, environmental, market fluctuations, and raw material price volatility in its management discussion[11]. - The company emphasizes the importance of investor awareness regarding the risks associated with forward-looking statements in the report[8]. - The company faces risks related to safety, environmental protection, industry policies, market fluctuations, and exchange rates[122]. - The company will enhance safety management and conduct comprehensive risk analysis to ensure stable production operations[123]. Research and Development - The company is focusing on innovation by increasing R&D investments in key intermediates, flame retardants, and nano new materials to ensure long-term development[35]. - The total R&D expenditure amounted to 263,536,551.05 yuan, representing 3.16% of total revenue[63]. - Research and development expenses increased by 11.06% to 263.54 million RMB, reflecting the company's commitment to innovation[49]. - The company applied for 29 patents in 2022, including 2 international patents, and received authorization for 15 patents[85]. - The company invested CNY 263.54 million in R&D in 2022, with 13 new projects initiated and 20 ongoing projects, resulting in 14 project outputs and 6 projects carried over to 2023[85]. Environmental Management - The company invested CNY 11,989,000 in environmental protection during the reporting period[183]. - A total of 62 environmental improvement projects were implemented, focusing on VOCs reduction, wastewater reduction, and dust control[184]. - The company achieved compliance with wastewater discharge standards, with COD emissions averaging 283.9 mg/L against a limit of 500 mg/L[187]. - The company maintained stable operation of all environmental protection facilities, ensuring compliance with emission standards[185]. - The company reported a decrease in emissions of major pollutants such as sulfur dioxide and nitrogen oxides compared to the previous year[184]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[193]. Governance and Compliance - The company has established a long-term mechanism to prevent major shareholders from infringing on the interests of the listed company[129]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with governance standards[130]. - The company emphasizes transparency in information disclosure, ensuring all shareholders have equal access to information[132]. - The company has revised its governance structure to ensure compliance with legal requirements and protect shareholder rights, particularly for minority shareholders[128]. Market Expansion and Strategy - The company is focusing on expanding its market presence through precise layout and scientific positioning, aiming to enhance sales scale[36]. - The company is enhancing its marketing strategies to stabilize sales volume and expand the sales area, variety, and volume of formulations[118]. - The company plans to advance the construction of its second and third production bases and implement key projects, including a 100,000-ton intelligent formulation project[113]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of $300 million earmarked for potential deals[146]. Leadership and Management - The company has seen leadership changes with Pang Changguo becoming the Chief Engineer in January 2023 after various roles since November 2011[148]. - The company reported a significant leadership presence in the agricultural technology sector, with Zhang Hua as Chairman of multiple subsidiaries since September 2021[149]. - The company has a strong management team with members holding key positions in shareholder units, such as Gu Jian Guo as Deputy Secretary and General Manager since December 2020[149]. - The leadership team has been stable, with many members serving in their roles for several years, ensuring continuity in management[148]. Employee Management - Employee motivation initiatives are being strengthened through stock incentives and positive reinforcement to enhance company cohesion[38]. - The company plans to implement a 40% key position training program and a 20% job rotation plan to cultivate backup talent[169]. - The company is focused on optimizing its salary system and implementing differentiated assessments for marketing and R&D personnel[167]. - A total of 53 young backbone employees were promoted, and 36 key positions were newly appointed during the reporting period[169].